Katherine R. Smith

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli”.

Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli

Nature(2020)10.1038/s41586-020-2080-8

N/A

8.3DataRank · unranked

1184 citations

Jens Puschhof, Axel Rosendahl Huber, Arne van Hoeck, Henry M. Wood, Jason Nomburg +95 more

Codon affinity in mitochondrial DNA shapes evolutionary and somatic fitness

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.23.537997

N/A

0.241DataRank · unranked

4 citations

Yajie Yin, Jacob C. Gutierrez, Ryan S. Dhindsa, Anne-Sophie Gribling-Burrer, Yu-Hsin Hsieh +25 more

Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis

Brain(2023)10.1093/brain/awad240

N/A

0DataRank · unranked

72 citations

Stefania Magri, Riccardo Curró, Elena Abati, Stefano Facchini, Marinella Corbetta +95 more

Variants in SART3 cause a spliceosomopathy characterised by failure of testis development and neuronal defects

Nature Communications(2023)10.1038/s41467-023-39040-0

N/A

0DataRank · unranked

24 citations

Stefanie Eggers, Ben Rollo, Katherine R. Smith, N. Davidson, Nicole A. Siddall +38 more

Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials

Vaccine(2023)10.1016/j.vaccine.2023.05.016

N/A

0DataRank · unranked

11 citations

Karim Hegazy, Miranda R. Cai, Irene McKnight, Matthew D. Rousculp, Katia Alves +1 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses

Vaccine(2023)10.1016/j.vaccine.2023.07.040

N/A

0DataRank · unranked

3 citations

Kinjal S. Patel, Katherine R. Smith, Robert Walker, Chengbin Wang, Ann M. Greene +5 more

Safety of the NVX-CoV2373 COVID-19 Vaccine in Randomized Placebo-Controlled Clinical Trials

medRxiv(2023)10.1101/2023.02.24.23285601

N/A

0DataRank · unranked

1 citations

Karim Hegazy, Miranda R. Cai, Irene McKnight, Matthew D. Rousculp, Katia Alves +1 more

Damaging mutations in LXRα uncouple lipogenesis from hepatotoxicity and implicate hepatic cholesterol sensing in human liver health

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.28.591512

N/A

0DataRank · unranked

1 citations

Milan Mušo, Ilona Zvetkova, Brian Lam, Alessandra Ferrari, Erik Schoenmakers +36 more

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

medRxiv(2021)10.1101/2021.10.05.21264567

N/A

0DataRank · unranked

37 citations

Karen L. Kotloff, Cynthia L. Gay, Germán Áñez, Jeffrey Adelglass, Alejandro Quintín Barrat Hernández +29 more